Ameliorating Effects of Ginger on Isoproterenol-Induced Acute Myocardial Infarction in Rats and its Impact on Cardiac

Mohammed Ahmed Hassanien1,2

  • 1Department of Pharmacy Practice, College of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.

Insights

Ginger extract offers a protective role against heart damage caused by Isoproterenol (ISO), primarily through its antioxidant and anti-inflammatory properties. This natural compound may help mitigate ISO-induced cardiotoxicity by influencing nitric oxide (NO) levels.

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Natural Product Chemistry

Background:

  • Myocardial infarction (MI) is a leading cause of global mortality and morbidity.
  • Isoproterenol (ISO)-induced MI is a validated model for studying cardioprotective agents.
  • Nitric Oxide (NO) plays a complex role, potentially contributing to oxidative stress in MI.

Purpose of the Study:

  • To evaluate the antioxidant and cardioprotective effects of ginger extract in a rat model of ISO-induced acute myocardial infarction.
  • To specifically investigate the impact of ginger on nitric oxide (NO) levels during ISO-induced cardiotoxicity.

Main Methods:

  • Forty male albino rats were divided into four groups: control, ginger extract only, ISO-induced MI, and ginger extract followed by ISO-induced MI.
  • Ginger extract was administered orally.
  • Myocardial infarction was induced via subcutaneous ISO administration.

Main Results:

  • Ginger extract demonstrated a significant protective role against ISO-induced myocardial infarction.
  • The cardioprotective effects are attributed to ginger's potent antioxidant and anti-inflammatory properties.
  • Ginger administration influenced nitric oxide (NO) levels, suggesting a role in modulating oxidative stress.

Conclusions:

  • Ginger extract effectively protects against acute myocardial infarction induced by ISO in rats.
  • The cardioprotective mechanism involves antioxidant and anti-inflammatory actions, potentially through modulation of nitric oxide pathways.
  • Further research, including immunohistochemical and biochemical studies, is warranted to elucidate the molecular mechanisms.
Abstract

Related Concept Videos

Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
683
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.8K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
951
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.0K
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
168